Business Description
Big Pharma Split Corp
NAICS : 523930
SIC : 7214
ISIN : CA08934P1080
Share Class Description:
FRA:XN4: Class ACompare
Compare
Traded in other countries / regions
PRM.CanadaXN4.Germany IPO Date
2022-08-04Description
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.3 | |||||
| 3-Year EPS without NRI Growth Rate | -34.1 | |||||
| 3-Year FCF Growth Rate | 30.7 | |||||
| 3-Year Book Growth Rate | -1.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.08 | |||||
| 9-Day RSI | 37.3 | |||||
| 14-Day RSI | 37.41 | |||||
| 6-1 Month Momentum % | -0.54 | |||||
| 12-1 Month Momentum % | -1.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 9.61 | |||||
| Dividend Payout Ratio | 1.26 | |||||
| Forward Dividend Yield % | 9.5 | |||||
| 5-Year Yield-on-Cost % | 11.8 | |||||
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | 14.94 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 77.61 | |||||
| FCF Margin % | 139.97 | |||||
| ROE % | 10.26 | |||||
| ROA % | 6.15 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.33 | |||||
| PE Ratio without NRI | 13.33 | |||||
| PS Ratio | 7.1 | |||||
| PB Ratio | 0.94 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| Price-to-Free-Cash-Flow | 5.11 | |||||
| Price-to-Operating-Cash-Flow | 5.11 | |||||
| EV-to-Revenue | 6.17 | |||||
| EV-to-FCF | 4.4 | |||||
| Price-to-Graham-Number | 0.75 | |||||
| FCF Yield % | 20.19 | |||||
| Forward Rate of Return (Yacktman) % | 16.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Big Pharma Split Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.471 | ||
| EPS (TTM) (€) | 0.67 | ||
| Beta | 0 | ||
| Volatility % | 13.3 | ||
| 14-Day RSI | 37.41 | ||
| 14-Day ATR (€) | 0.100776 | ||
| 20-Day SMA (€) | 9.0125 | ||
| 12-1 Month Momentum % | -1.07 | ||
| 52-Week Range (€) | 8.65 - 10.2 | ||
| Shares Outstanding (Mil) | 1.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Big Pharma Split Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Big Pharma Split Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Big Pharma Split Corp Frequently Asked Questions
What is Big Pharma Split Corp(FRA:XN4)'s stock price today?
The current price of FRA:XN4 is €8.70. The 52 week high of FRA:XN4 is €10.20 and 52 week low is €8.65.
When is next earnings date of Big Pharma Split Corp(FRA:XN4)?
The next earnings date of Big Pharma Split Corp(FRA:XN4) is .
Does Big Pharma Split Corp(FRA:XN4) pay dividends? If so, how much?
The Dividend Yield %  of Big Pharma Split Corp(FRA:XN4) is 9.61% (As of Today), Highest Dividend Payout Ratio of Big Pharma Split Corp(FRA:XN4) was 1.26. The lowest was 0.38. And the median was 0.58. The  Forward Dividend Yield % of Big Pharma Split Corp(FRA:XN4) is 9.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers